Recombinant Human Anti-Insulin precursor Soluble TCR (E2.3) (C-Cys) (CAT#: VS-0622-YF3943)
Human TCR (E2.3) recognizes Insulin precursor peptide (QPLALEGSL) in the context of . Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- Insulin precursor
- Species Reactivity
- Human
- Epitope
- QPLALEGSL
- Clone
- E2.3
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Others
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- Hypothetical Protein
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone E2.3"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF3943. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, IP, IF, FuncS, FC, Neut, ELISA
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: ELISA, FC, WB, Block
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, FC, IHC, IF, IP
Application: ELISA, FuncS, RIA, IP, IF, IHC, IA, Block
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
